Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper

Benjamin B. Swart,Charles Reznikoff,Katie Steen
DOI: https://doi.org/10.1097/adm.0000000000001328
2024-10-03
Journal of Addiction Medicine
Abstract:This case report highlights a 36-year-old male without history of psychiatric disease, chronic pain, or substance use disorder who developed severe substance use disorder per Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition criteria to kratom. He was successfully treated with sublingual buprenorphine after a 3-year period of intermittent withdrawal management and trials of oral and extended-release injectable naltrexone. After a period of abstinence from kratom, he was tapered from buprenorphine using 2 monthly injections of 100 mg extended-release buprenorphine. His case underscores some of the current uncertainties around kratom use disorder diagnosis and treatment.
substance abuse
What problem does this paper attempt to address?